Since the 1940s, sexually transmitted ...

Scientists have discovered a new strain of bacteria in Japan, which are resistant to existing treatments. Since the 1940s, sexually transmitted disease known as "kick" was easily treated. But a new strain of gonococci was genetically mutated avoid cephalosporins - only antibiotics still effective against infection. "It's as predictable and disturbing discovery," lead researcher Magnus Unemo, Professor Swedish reference laboratory for pathogenic Neisseria in Örebro, Sweden, said in a statement. "Because antibiotics have become the standard treatment for gonorrhea in 1940, this bacterium has shown remarkable ability to develop mechanisms of resistance to all drugs submitted to control it."

Open Unemo announced at the International Society for Sexually Transmitted Disease Research meeting in Quebec, Canada, the transition could hail from gonorrhea curable STDs to a global threat to public health. "It is still too early to assess if this new strain is widespread, the history of emerging resistance in bacteria that it can spread rapidly if new medicines and effective treatment programs developed" Unemo said in a statement. Cephalosporin resistant gonococci connections and I'm ominous class of bacteria known as superbakteriy. But unlike nosocomial MRSA and VRE, which is super gonorrhea can spread to anywhere. "The report notes that resistance to antibiotics that occurs not only in hospitals but in the community," said Dr. William Schaffner, Department of Preventive Medicine Vanderbilt University Medical Center in Nashville, Tennessee, and while the strain disovered in Kyoto, Japan, antibiotic-resistant bacteria "do not need a passport."

Resistance to antibiotics is not a new phenomenon - even for gonococci that produced resistance to several other antibiotics used before cephalosporins. "We were concerned about this 20 years ago, and fight, which is very effective," Schaffner said, explaining how gonorrhea treatment evolved with bacteria. "But if you stress that it is completely resistant to antibiotics, you should quickly develop strategies recognize resistant strain and alternative treatment regimens."

This test new treatments and can be developed, Schaffner said, but they will strattera cost likely be more expensive. Among the cuts in all aspects of research, pharmaceutical companies invest less in search of new antibiotics, he said. With an estimated 700,000 new cases annually in the U.S. alone, gonorrhea is one of the most common sexually transmitted diseases. It spreads through direct contact with the penis, vagina, mouth or anus and can be transmitted from mother to child during childbirth. But only 50 percent of infected women and less than five percent of infected women develop symptoms such as burning and discharge. If untreated, the infection can spread to the skin, blood and other organs, causing pain, infertility and even death. A July 8, 2011, Report U.S. Centers for Disease Control and Prevention urges doctors to be alert for gonorrhea resistant to cephalosporins and report cases promptly. New Superbug is a reminder that resistance to antibiotics is a problem that extends beyond the walls of hospitals and nursing homes. "We must implement a program so that pharmaceutical companies financially motivated to conduct research in the development of antibiotics," Schaffner said. "As public and professional need to be more rigorous in their expectations and use of antibiotics."